Lippincott's Nursing Drug Guide 2005 (Canadian)

(6)
Lippincott's Nursing Drug Guide 2005 (Canadian) image
ISBN-10:

1582553440

ISBN-13:

9781582553443

Author(s): Karch
Edition: 1
Released: Jan 01, 2004
Format: Paperback, 1470 pages
Related ISBN: 9781582554099

Description:

Updated for 2005, this guide contains over 800 complete drug monographs, organized alphabetically for easy access. Each monograph covers generic and trade names; special designation for OTC drugs; pregnancy risk category; controlled substance schedule if appropriate; drug class; therapeutic actions; indications, including unlabeled indications; contraindications and cautions; dosage; pharmacokinetics; IV facts section; adverse effects; interactions; assessment; intervention; and teaching points. The book includes a full-color photoguide to pills and capsules, details on preventing and reporting medication errors, and over 20 appendices, including cardiovascular guidelines, intramuscular and subcutaneous administration sites, and drugs that interact with grapefruit juice. Drug updates and continuing education tests are available at NursingDrugGuide.com.

Best prices to buy, sell, or rent ISBN 9781582553443




Frequently Asked Questions about Lippincott's Nursing Drug Guide 2005 (Canadian)

You can buy the Lippincott's Nursing Drug Guide 2005 (Canadian) book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $43.99 on Amazon and is available from 1 sellers at the moment.

If you’re interested in selling back the Lippincott's Nursing Drug Guide 2005 (Canadian) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Lippincott's Nursing Drug Guide 2005 (Canadian) book, the best buyback offer comes from and is $ for the book in good condition.

Not enough insights yet.

Not enough insights yet.